Zanamivir (Relenza) and Oseltamivir (Tamiflu)
- Influenza A and B
 - Treatment and Prophylaxis
 - Inhibits Release of New Virus
 - Inhibits Influenza Neuraminidase
 
Influenza Virus
- RNA Virus
 - Orthomyxovirus
 - Enveloped
 - Negative Sense
 - 8 Segments
 - Helical
 - Hemagglutinin for Viral Entry
 - Neuraminidase for Virion Release
 - Genetic Shift
 - Reassortment of genome to cause major change
 - Genetic Drift
 - Minor Antigenic Mutations
 - Reye Syndrome with Aspirin Use
 - Guillain-Barre Syndrome
 
Influenza
- High Fever
 - Cough
 - Headache
 - Muscle Aches
 - Chills
 - Vaccination
 - Zanamivir (Relenza)
 - Oseltamivir (Tamiflu)
 
Herpes Simplex Virus (HSV)
- Enveloped
 - Double Stranded DNA
 - Linear
 - Type 1 HSV
 - Gingivostomatitis
 - Keratoconjunctivitis
 - Encephalitis of Temporal Lobes
 - Latent in Trigeminal Ganglia
 - Type 2 HSV
 - Genital Vesicles
 - Neonatal Herpes
 - TORCHES
 - Latent in Sacral Ganglia
 - Tzanck Test
 - Multinucleated Giant Cells
 - Cowdry A Inclusions
 - Acyclovir
 
Cytomegalovirus (CMV)
- Enveloped
 - Double Stranded DNA
 - Herpesvirus 5
 - Non Heterophile Antibodies
 - Owl's eye inclusions
 - Congenital TORCH infection
 - Mononucleosis
 - Pneumonia
 - AIDS retinitis and esophagitis
 - Infection in transplant recipients
 
Cytomegalovirus (CMV) TORCH
- Nonspecific TORCH symptoms
 - Intrauterine Growth Restriction (Retardation)
 - Deafness
 - Microcephaly
 - Seizures
 - Periventricular Calcifications
 - Petechial Rash
 - Blueberry Muffin Rash
 - Chorioretinitis
 - Urine Viral Culture or PCR
 
Genital Herpes
- Herpes Simplex Virus 1 and 2 (HSV)
 - May Be Asymptomatic
 - Oral or Genital Lesions
 - Vesicles in Clusters
 - Pain
 - Flu-like Symptoms
 - Acyclovir
 - Valacyclovir
 - Famciclovir
 - Infectious During Recurrences
 
Acyclovir (Zovirax)
- Guanosine Analog
 - Inhibits Viral Replication
 - Thymidine Kinase Activation
 - Herpes Simplex Virus (HSV)
 - Varicella Zoster Virus (VZV)
 - Headache
 - GI Distress
 - CNS Toxicity
 - Nephrotoxicity (Crystalline Nephropathy)
 - Prevents Recurrent Episodes
 - Slow IV Infusion
 
Human Immunodeficiency Virus (HIV) Diagnosis
- HIV-1/2 Antigen/Antibody Immunoassay
 - HIV-1/2 Antibody Differentiation Immunoassay
 - Nucleic Acid Testing (NAT)
 - Viral Load
 - Polymerase Chain Reaction (PCR) in Neonates
 
Ganciclovir
- Cytomegalovirus (CMV)
 - Immunocompromised
 - Guanosine Analog
 - Disrupts DNA Synthesis
 - Inhibits Viral DNA Polymerase
 - Hematologic Effects
 - Nephrotoxicity
 
Human Immunodeficiency Virus (HIV) Interventions
- Adequate Nutrition
 - Small Frequent Meals
 - IV Hydration
 - Emotional Support
 - HAART
 - Transmission Education
 - Strict Asepsis for Invasive Procedures
 - Treat Opportunistic Infections
 
Human Immunodeficiency Virus (HIV) Stages
- Primary Infection
 - Within 3 Weeks
 - Flu-like Symptoms
 - Asymptomatic Stage
 - Years
 - Symptomatic Stage
 - CD4+ < 500
 - AIDS
 - Opportunistic Infections
 - CD4+ < 200
 
Human Immunodeficiency Virus (HIV) Assessment
- RNA Retrovirus
 - CD4+ Helper T Cells
 - Flu-like Symptoms
 - Lymphadenopathy
 - Fatigue
 - Diarrhea
 - Unexplained Weight Loss
 - White Spots on Tongue
 - Persistent Fever
 - Night Sweats
 
Respiratory Syncytial Virus (RSV) Assessment
- Viral Infection Affecting Epithelial Cells
 - Begins After a Upper Respiratory Infection
 - Copious Secretions
 - Coughing and Sneezing
 - Wheezing
 - Otitis Media or Conjunctivitis (Possible Ear or Eye Drainage)
 - Poor Feeding
 - Tachypnea
 
Respiratory Syncytial Virus (RSV) Interventions
- Palivizumab (Synagis)
 - Hospitalization
 - Contact Precautions
 - Oxygen
 - Separate Room
 - Maintain Fluid Intake
 - Short-acting Beta-Agonist Bronchodilator
 
Hepatitis C
- Enveloped
 - RNA Virus
 - Flavivirus
 - Icosahedral
 - SS positive Linear
 - Most Cases are Due to IV Drug Use
 - Turns to Chronic Hepatitis in Over 70% of Cases
 - Cirrhosis
 - Hepatocellular Carcinoma
 - Most Common Indication for Liver Transplantation
 - Associated With Type I MPGN
 - Porphyria Cutanea Tarda
 
Hepatitis A
- Picornavirus
 - 4 Week Incubation Period
 - Fecal-oral
 - Day Care Centers
 - Travel to Developing Countries
 - Usually Asymptomatic
 - Acute Disease
 - Jaundice
 - Fever
 - Vomiting
 
Foscarnet
- CMV Retinitis
 - Acyclovir-resistant HSV
 - Does Not Require Activation (by Viral Kinase)
 - Inhibits Viral DNA Polymerase
 - Pyrophosphate Analog
 - Resistance through Mutated DNA Polymerase
 - Nephrotoxicity
 - Electrolyte Abnormalities
 - Hypokalemia
 - Hypocalcemia
 - Hypomagnesemia
 
Fusion Inhibitors
- HIV
 - Maraviroc
 - Binds CCR-5 on T Cells
 - Blocks Interaction with gp120
 - Enfuvirtide
 - Binds gp41
 - Inhibits Viral Entry
 - Skin Reactions at Injection Sites (Enfuvirtide)
 
Integrase Inhibitors
- -gravir Suffix
 - HIV
 - Blocks Insertion of Viral Genome
 - Inhibit Actions of Integrase
 - Hypercholesterolemia
 - Increased LFT's
 - Insomnia
 - Increased Creatine Kinase (CK)
 
NRTIs for HIV (Drug Names)
- DEALSZ
 - Didanosine (DDI)
 - Emtricitabine (FTC)
 - Abacavir (ABC)
 - Lamivudine (3TC)
 - Stavudine (d4T)
 - Zidovudine (ZDV)
 - Tenofovir (TDF)
 
Cidofovir
- CMV Retinitis
 - Acyclovir-Resistant HSV
 - Inhibits Viral DNA Polymerase
 - Nephrotoxicity
 - Administer with Probenecid and IV Saline
 
NNRTI Drug Names
- Nevirapine (Viramune)
 - Rilpivirine (Edurant)
 - Delavirdine (DLV, Rescriptor)
 - Efavirenz (EFV, Sustiva)
 - Etravirine (ETR, Intelence)
 
NRTIs (Nucleoside Reverse Transcriptase Inhibitors)
- HIV
 - Pregnancy and Prophylaxis given ZDV
 - Inhibit Nucleotide Binding to Reverse Transcriptase
 - Chain Termination
 - Require Phosphorylation
 
NNRTIs (Non-nucleoside Reverse Transcriptase Inhibitors)
- HIV
 - Do Not Require Intracellular Metabolism
 - Inhibits Reverse Transcriptase
 - Rash
 - Hepatotoxicity
 - Vivid Dreams and CNS Symptoms
 - Pregnancy